Previous studies have demonstrated that overexpression of GRP78/BiP, an endoplasmic reticulum (ER)-resident molecular chaperone, in mammalian cells inhibits the secretion of specific coagulation factors. However, the effects of GRP78/BiP on activation of the coagulation cascade leading to thrombin generation are not known. In this study, we examined whether GRP78/BiP overexpression mediates cell surface thrombin generation in a human bladder cancer cell line T24/83 having prothrombotic characteristics. We report here that cells overexpressing GRP78/BiP exhibited significant decreases in cell surface-mediated thrombin generation, prothrombin consumption and the formation of thrombin-inhibitor complexes, compared with wild-type or vector-transfected cells. This effect was attributed to the ability of GRP78/BiP to inhibit cell surface tissue factor (TF) procoagulant activity (PCA) because conversion of factor X to Xa and factor VII to VIIa were significantly lower on the surface of GRP78/BiP-overexpressing cells. The additional findings that (i) cell surface factor Xa generation was inhibited in the absence of factor VIIa and (ii) TF PCA was inhibited by a neutralizing antibody to human TF suggests that thrombin generation is mediated exclusively by TF. GRP78/BiP overexpression did not decrease cell surface levels of TF, suggesting that the inhibition in TF PCA does not result from retention of TF in the ER by GRP78/BiP. The additional observations that both adenovirus-mediated and stable GRP78/BiP overexpression attenuated TF PCA stimulated by ionomycin or hydrogen peroxide suggest that GRP78/BiP indirectly alters TF PCA through a mechanism involving cellular Ca 2؉ and/or oxidative stress. Similar results were also observed in human aortic smooth muscle cells transfected with the GRP78/BiP adenovirus. Taken together, these findings demonstrate that overexpression of GRP78/BiP decreases thrombin generation by inhibiting cell surface TF PCA, thereby suppressing the prothrombotic potential of cells.
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In eukaryotic cells, the endoplasmic reticulum (ER) 1 is the cellular organelle where secretory proteins or proteins destined for the plasma membrane undergo a variety of modifications, including disulfide bond formation, glycosylation, folding, and oligomeric assembly. The inability of nascent polypeptide chains to fold into their native conformation generally leads to retention in the ER and degradation (1) . To assist in the correct folding of newly synthesized proteins and to prevent aggregation of folding intermediates, the ER contains a wide range of molecular chaperones such as the glucose-regulated proteins, calnexin, calreticulin, protein-disulfide isomerase, and Erp72 (2, 3) . These chaperones are postulated to act as a quality control system by ensuring that only correctly folded proteins are processed prior to entering the Golgi apparatus for further processing and secretion (2) (3) (4) . In addition to their function as molecular chaperones, recent studies have demonstrated that some of these ER proteins protect cells against oxidative stress (5) (6) (7) .
Prominent among the ER-resident chaperones is the 78-kDa glucose-regulated protein/immunoglobulin-binding protein (GRP78/BiP), a highly conserved member of the 70-kDa heat shock protein family (8, 9 ) and a major ER luminal Ca 2ϩ storage protein (10, 11) . GRP78/BiP transiently associates with correctly folded proteins but forms more stable complexes with misfolded or incompletely assembled proteins (1, 4, 12) . This association involves the binding of GRP78/BiP to hydrophobic motifs exposed on unfolded or unassembled polypeptides (13) (14) (15) . Proteins stably bound to GRP78/BiP are subsequently translocated from the ER into the cytosol for proteasome-dependent degradation (16, 17) . The observation that GRP78/BiP is induced by conditions of stress that result in the accumulation of misfolded or underglycosylated proteins in the ER (8, 9) provides further evidence that GRP78/BiP plays a critical role in quality control processes during protein synthesis and folding.
Recent studies have demonstrated that alterations in GRP78/BiP protein levels mediate selective changes in the abundance of membrane or secretory proteins that transit the ER. In mammalian cells, reduced levels of GRP78/BiP increase the secretion of factor VIII and a mutant form of tissue plas-minogen activator lacking glycosylation sites (18 -20) . In contrast, elevated levels of GRP78/BiP decrease the secretion of von Willebrand factor (vWf) and factor VIII (18 -20) . Although these studies provide convincing evidence that alterations in GRP78/BiP levels lead to selective changes in the processing and secretion of certain coagulation factors, the effect of GRP78/BiP on the prothrombotic potential of cells was not investigated.
The major physiological initiator of the extrinsic coagulation cascade is tissue factor (TF), a 47-kDa transmembrane glycoprotein (21) (22) (23) (24) . TF initiates the coagulation cascade by complexing with factor VII/VIIa on the surface of cells, leading to the activation of factors IX and X and the subsequent generation of thrombin. TF expression is increased in atherosclerotic plaques (25) (26) (27) (28) (29) (30) (31) and in vascular smooth muscle cells following balloon injury (32) . Infection with adenovirus, as well as other respiratory viruses, increases TF expression and procoagulant activity (PCA) (33) . Growth factors (34) and cytokines (35, 36) , endotoxin (37, 38) , hypoxia (39) , cell injury (40) , reactive oxygen species (ROS) (41) (42) (43) , oxidized LDL (44 -46) , and increases in intracellular free Ca 2ϩ (47) (48) (49) (50) are also known to induce TF PCA in a variety of cell types, including vascular endothelial cells, smooth muscle cells, and circulating monocytes. Furthermore, the majority of tumor cells express TF (51) (52) (53) (54) , and the prothrombotic state observed in cancer patients has been largely attributed to this expression (53) .
Given that TF transits the ER prior to its localization in the plasma membrane, we have postulated that GRP78/BiP overexpression could potentially alter the prothrombotic potential of cells. In this study, GRP78/BiP was stably overexpressed in a human bladder cancer cell line T24/83 having prothrombotic characteristics. Our findings indicate that overexpression of GRP78/BiP significantly decreases TF-mediated cell surface thrombin generation. The finding that GRP78/BiP overexpression fails to decrease cell surface levels of TF suggests that the inhibition of TF PCA by GRP78/BiP does not result from the retention of TF in the ER. The ability of GRP78/BiP overexpression to attenuate TF PCA induced by ionomycin, hydrogen peroxide, or adenovirus supports a mechanism involving cellular Ca 2ϩ and/or oxidant stress. These findings show that GRP78/BiP overexpression decreases TF PCA and provides novel evidence that alterations in the levels of GRP78/BiP can have profound effects on the prothrombotic potential of cells.
EXPERIMENTAL PROCEDURES
Cell Culture and Treatment Conditions-The human transitional bladder carcinoma cell line T24/83 was obtained from the American Type Culture Collection and cultured in M199 medium containing 10% fetal bovine serum (FBS), 100 g/ml penicillin, and 100 g/ml streptomycin in a humidified incubator at 37°C with 5% CO 2 . Although previous studies classified T24/83 cells as an immortalized human umbilical vein endothelial cell line, designated ECV304 (55), recent genetic analysis and functional responses have demonstrated that ECV304 cells are indeed T24/83 (56) . Human aortic smooth muscle cells (HASMC) were purchased from Cascade Biologicals (Portland, OR) and cultured in medium 231 containing 20% smooth muscle growth supplement and PSA solution (100 units/ml penicillin, 100 g/ml streptomycin, and 0.25 g/ml amphotericin) (Cascade Biologicals).
Establishment of Stable T24/83 Cell Lines Overexpressing GRP78/ BiP-Construction of the mammalian expression vector, pcDNA3.1(ϩ)-GRP78/BiP, encoding human GRP78/BiP and the establishment of stable T24/83 cell lines overexpressing human GRP78/BiP have been described previously (57) . As a vector control, T24/83 cells were transfected with pcDNA3.1(ϩ) under the same conditions. Overexpression of GRP78/BiP was assessed by indirect immunofluorescence and immunoblot analysis, as described below.
Immunoblot Analysis-Monoclonal and polyclonal antibodies to human TF were purchased from American Diagnostica (Greenwich, CT). The anti-KDEL monoclonal antibody (SPA-827), which recognizes both GRP78/BiP and GRP94, was purchased from StressGen Biotechnologies (Victoria, BC). Total protein lysates from T24/83 cells were solubilized in Laemmli sample buffer (50 mM Tris, pH 6.8, 2% SDS, 10% glycerol, 1% ␤-mercaptoethanol, 0.01% bromphenol blue), separated on SDS-polyacrylamide gels under reducing conditions and transferred to nitrocellulose membranes (Bio-Rad), as described previously (58) . After incubation with the appropriate primary and horseradish peroxidase (HRP)-conjugated secondary antibodies (Affinity Biologicals, Hamilton, ON), the membranes were developed using the Renaissance chemiluminescence reagent kit (PerkinElmer Life Sciences).
Indirect Immunofluorescence and Image Analysis-Polyclonal antibodies to GRP78/BiP (sc-1050) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Immunofluorescence for GRP78/BiP was performed as described previously (58, 59) . For detection of cell surface levels of TF, cells were washed with ice-cold 1ϫ PBS for 2 min, blocked with 3% BSA in 1ϫ PBS for 1 h at 4°C and incubated with an antihuman TF monoclonal antibody (5 g/ml) for 1 h at 4°C. After three washes with 1ϫ PBS containing 0.5% BSA, cells were incubated with the appropriate Alexa-labeled secondary antibody (BioLynx, Brockville, ON) for 1 h at 4°C, washed again, and fixed with 1% paraformaldehyde. Images were subsequently captured and analyzed using Northern Exposure image analysis/archival software (Mississauga, ON).
Immunoprecipitation of Cell Surface TF-Cell surface TF was immunoprecipitated essentially as described previously (42) . Briefly, antihuman TF polyclonal antibodies at 0.5 g/ml in FBS-free M199 medium were added to cell monolayers at 4°C for 2 h. After washing twice with ice-cold 1ϫ PBS, cells were lysed in ice-cold RIPA buffer (50 mM Tris, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS) containing protease inhibitors (Roche Diagnostics, Laval, QC), and cell surface TF protein was immunoprecipitated from total cell protein by overnight incubation with protein A-Sepharose-linked beads (Pierce). After washing with RIPA buffer, the beads were boiled in Laemmli sample buffer, and the immunoprecipitates were separated on 10% SDS-polyacrylamide gels under reducing conditions. Gels were transferred to nitrocellulose membranes and immunoblotted with anti-human TF polyclonal antibodies, as described above.
Biotinylation of Cell Surface Proteins-Cell surface biotinylation was performed as described previously (60, 61) . Briefly, cell monolayers were washed once with ice-cold FBS-free M199 medium and three times with ice-cold 1ϫ PBS to remove residual FBS and other proteins from the culture medium. PBS containing 1 mg/ml EZ Link NHS-SS-Biotin (Pierce) was added to the monolayers, and the biotinylation reaction was carried out at room temperature for 30 min with gentle shaking. Following three washes with ice-cold 1ϫ PBS, cells were solubilized in Laemmli sample buffer. Proteins were separated on 10% SDS-polyacrylamide gels and transferred to nitrocellulose membranes. To detect biotinylated cell surface proteins, immunoblot analysis was performed using HRP-conjugated ExtrAvidin (Sigma).
Thrombin Generation-Thrombin generation studies were conducted with either control pooled plasma from healthy adults or factor VIIdeficient plasma (Affinity Biologicals). Factor VII levels in the deficient plasmas were Յ1%, according to the manufacturer. Prior to use in the thrombin generation assay, plasmas were defibrinated using arvin and total amidolytic activity of thrombin generated on cell surfaces was measured as previously described (62, 63) . Cell monolayers in 24-well plates were placed on a Thermolyne dri-bath set at 37°C. After washing twice with 1 ml of acetate/barbital/saline (ABS) buffer (0.036 M sodium acetate, 0.036 M sodium diethylbarbitarate, 0.145 M NaCl, pH 7.4), monolayers were incubated for 3 min with 100 l of ABS buffer and 200 l of defibrinated plasma, in the absence or presence of 10% activated partial thromboplastin time (APTT) reagent (Organon Teknika Corp., Durham, NC). At time periods up to 30 min following the addition of 100 l of 40 mM CaCl 2 in ABS buffer, 25-l aliquots of the reaction mixture on the surface of the cells were removed and mixed with 475 l of 5 mM EDTA on ice. 25 l of each EDTA sample were then mixed with 775 l of 0.16 mM S-2238 (KabiVitum, Stockholm, Sweden) in buffer and heated at 37°C for 10 min prior to termination of the amidolytic reaction with 200 l of 50% acetic acid. The absorbance at 405 nm was measured and the concentration of total thrombin determined by comparing results to a standard curve generated with purified thrombin in S-2238. EDTA samples were also used to measure the concentrations of prothrombin, thrombin-antithrombin (TAT) complexes and thrombinheparin cofactor II complexes. Prothrombin, TAT, and thrombin-heparin cofactor II complexes were assayed using commercially available ELISA kits (Affinity Biologicals). Because thrombin bound to ␣ 2 macroglobulin (␣ 2 M) retains amidolytic activity against S-2238 (64), the contribution of thrombin-␣ 2 M to total thrombin activity was measured as previously described (63) . Briefly, the amidolytic activity of total thrombin was measured as described above, except that the 25-l reaction mixture taken at each time point was incubated with 3.5 l of 0.15 M NaCl containing 0.25 units of standard heparin and 0.042 units of antithrombin (to inhibit any free thrombin) for 1 min on ice, followed by the addition of 475 l of 5 mM EDTA. ␣ 2 M-dependent thrombin activity was then subtracted from the total thrombin activity to give the amount of physiologically active free thrombin generated by the cell surface.
Prothrombin Consumption-EDTA samples were used to determine prothrombin consumption during the experiments. Prothrombin concentrations were determined for each time point during the thrombin generation experiments using a commercially available ELISA kit. Control plasma with a known concentration of prothrombin was used as a standard.
Factor VII Activation Assay-Factor VIIa generation on the surface of T24/83 cells was performed by a one-step assay, which directly measures the conversion of factor VII to factor VIIa, using the chromogenic substrate S-2288 (65) . Cell monolayers were washed twice in ABS buffer and incubated for time periods up to 30 min in the absence (blank control) or presence of 108 nM recombinant human factor VII (Enzyme Research Laboratories, South Bend, IN) and 5 mM Ca 2ϩ in ABS buffer. The generation of factor VIIa was assessed by subsampling cell surface supernatant into S-2288, followed by incubation at 37°C for 30 min. After termination with 50% acetic acid, absorbance at 405 nm was determined for each sample. The rates of factor VIIa formation in the various samples were calculated based on a standard curve using known amounts of human factor VIIa (Enzyme Research Laboratories) and TF (Thromborel S, Dade Behring, Newark, DE).
Cell Surface Tissue Factor Activity Assay-Cell surface TF activity, measured as the amount of factor Xa generated, was performed as described previously (66, 67) . Briefly, cells were seeded onto 24-well tissue culture plates and upon reaching confluence, the culture medium was removed, and the cells were washed once with 1ϫ PBS and incubated with FBS-free medium for 1 h at 37°C. Cells in FBS-free medium were untreated or treated with ionomycin (5-10 M for 10 min) or hydrogen peroxide (10 mM for 1 h). Cells were washed twice with 1ϫ TBS (50 mM Tris, 120 mM NaCl, 2.7 mM KCl, 3 mg/ml BSA, pH 7.4) and incubated with 300 l of 1ϫ TBS containing 0.5 nM human factor VIIa and 15 nM human factor X (Enzyme Research Laboratories). Activation of factor X was initiated by the addition of 5 mM CaCl 2 for 30 min at 37°C. 250-l aliquots were removed and incubated with 25 l of chromogenic substrate S-2765 (0.2 mM) (DiaPharma, West Chester, OH) for 3 min at 37°C. The reaction was terminated using 20 l of 50% acetic acid, and the absorbance at 405 nm was measured using a microplate reader. Standards containing the reaction mixture and various amounts of rabbit brain thromboplastin (Thromboplastin C Plus, Dade Behring) were also prepared and incubated with S-2765 as described above. The absorbance at 405 nm was determined and used to generate a standard curve where 100 units of TF activity was defined as the amount of activity in 1 l of rabbit brain thromboplastin. Cells in the 24-well plates were lysed in RIPA buffer, and the amount of total protein was measured using the D C Protein Assay (Bio-Rad) according to the manufacturer's instructions. Absorbances were measured at 750 nm and the amount of total protein calculated by comparing the OD 750 with reference standards of Bio-Rad Protein Assay Standard II. Cell surface TF PCA was calculated as the amount of factor Xa generated per g of total protein (units/g).
Adenoviral Infection-The construction and large scale preparation of recombinant adenoviral vectors expressing GRP78/BiP (AdV-GRP78) or ␤-galactosidase (AdV-␤-Gal) were performed essentially as previously described (68) . Wild-type T24/83 cells or HASMC were grown in appropriate medium until reaching 70% confluence. Cells were washed once with 1ϫ PBS and infected with either AdV-GRP78 or AdV-␤-Gal at multiplicities of infection (m.o.i.) of 100, 300, or 500 pfu/cell, in FBS-free medium for 30 min at 37°C. Cells were incubated in medium containing FBS for 72 h at 37°C. Media was removed, and cells were washed once in 1ϫ PBS prior to cell surface TF PCA assay or lysate preparation for immunoblotting, as described above.
Statistical Analysis-Data represent the mean Ϯ S.E. Significance of differences between control and GRP78/BiP-overexpressing cells was determined by analysis of variance (ANOVA). On finding significance with ANOVA, unpaired Student's t test was performed. For all analyses, p Ͻ 0.05 was considered significant.
RESULTS
Previous studies have demonstrated that non-stimulated T24/83 cells constitutively express both TF mRNA and antigen, which correlate with an increase in cell surface TF levels and activity (69 -71) . TF PCA in unstimulated T24/83 cells is significantly greater than other cells lines, including human umbilical vein endothelial cells and unstimulated monocytes (69, 70) . Furthermore, TF expression in T24/83 cells was increased by phorbol myristate acetate, a known inducer of TF mRNA and protein in a wide variety of cultured cells (69) . Based on these findings and given the important role of TF in blood coagulation and thrombosis, T24/83 cells were selected as our model system to study the effect of GRP78/BiP overexpression on TF-dependent thrombin generation.
Stable Overexpression of GRP78/BiP in T24/83 Cells-T24/83 cells were transfected with either the pcDNA3.1(ϩ)-GRP78/BiP expression vector or pcDNA3.1(ϩ) alone and stable transfectants selected in complete medium containing G418. Total cell lysates isolated from wild-type or stably transfected T24/83 cells were analyzed for GRP78/BiP protein by immunoblot analysis using an anti-KDEL monoclonal antibody, which recognizes both human GRP78/BiP and GRP94. As shown in Fig. 1A , two independently isolated G418-resistant cell lines, c1 and c2 (designated T24/83-GRP78c1 and c2, respectively) exhibited a 3.3-fold increase in GRP78/BiP protein levels, compared with wild-type or vectortransfected cells. In contrast, GRP94 was unchanged in all cell lines, suggesting that alterations in GRP78/BiP protein levels do not alter endogenous GRP94 protein levels. To compare the cellular levels and distribution of GRP78/BiP protein, wild-type, vectortransfected, or GRP78/BiP-overexpressing cells cultured on coverslips were fixed, permeabilized, and examined by indirect immunofluorescence using anti-GRP78/BiP polyclonal antibodies. In both wild-type and GRP78/BiP-overexpressing cells, GRP78/BiP was concentrated in the perinuclear region, consistent with its location in the ER (Fig. 1B) . However, the fluorescence intensity was much greater in the GRP78/BiP-overexpressing cells, compared with wild-type and vector-transfected cells. Nonspecific immunostaining was not detected in cells in which the primary antibody had been omitted or in which preimmune mouse IgG was substituted for the primary antibody (data not shown). In terms of cellular function, overexpression of GRP78/BiP suppressed the induction of endogenous GRP78/BiP mRNA levels and increased survival of T24/83 cells exposed to the ER stress-inducing agent, A23187 (data not shown), findings consistent with those observed in GRP78/BiP-overexpressing CHO cells (7) . GRP78/BiP protein levels present in the stable GRP78/BiPoverexpressing cell lines were comparable to levels observed in wild-type cells treated with known ER stress-inducing agents, including homocysteine, dithiothreitol, and tunicamycin (Fig.  1C) . This observation suggests that the levels of GRP78/BiP observed in these stable cell lines are within the range that can be attained under physiological conditions of ER stress. However, unlike the GRP78/BiP-overexpressing cell lines, cells treated with ER stress-inducing agents had an expected increase in GRP94 protein levels.
Overexpression of GRP78/BiP Decreases Thrombin Generation, Prothrombin Consumption, and the Formation of Thrombin-Inhibitor Complexes on the Surface of T24/83 CellsThrombin generation, prothrombin consumption, and formation of thrombin-inhibitor complexes were determined using normal defibrinated human plasma. In control plasma, after the addition of Ca 2ϩ , the concentration of physiologically active free thrombin generated on the surface of wild-type or vectortransfected cells increased significantly between 2 and 22 min (p Ͻ 0.001), with peak concentrations reaching 110 Ϯ 16 and 131 Ϯ 2 nM, respectively, by 4 min (Fig. 2A) . In contrast, the concentration of free thrombin generated on the surface of the stable GRP78/BiP-overexpressing cell lines was negligible for all time points examined, up to 25 min. Consistent with these findings, both prothrombin consumption (Fig. 2B) and formation of thrombin-inhibitor complexes (Table I) were signifi-cantly reduced in the stable GRP78/BiP-overexpressing cells, compared with wild-type or vector-transfected cells (p Ͻ 0.001).
Overexpression of GRP78/BiP Inhibits TF-dependent Factor VII and Factor X Activation-Factor VII-depleted plasma was used to initially determine whether GRP78/BiP overexpression may have selectively impaired a component of the extrinsic pathway such as TF. Thus, in the presence of factor VII-depleted plasma, free thrombin generation and prothrombin consumption were negligible for all cell lines over the 25-min time period (data not shown), a result consistent with the requirement of factor VIIa for TF-dependent thrombin generation (62) (63) (64) (65) . To specifically examine TF PCA on cell surfaces, wildtype, vector-transfected, or GRP78/BiP-overexpressing cells were grown to confluency and factor Xa generation was measured over 30 min using the chromogenic substrate S-2765. As shown in Fig. 3A , the rate of factor Xa generation was significantly decreased in the GRP78/BiP-overexpressing cells, com- , vectortransfected (pcDNA) or GRP78/BiP-overexpressing (GRP78c1) cells grown on glass coverslips were fixed, permeabilized, and incubated with an anti-human GRP78/BiP antibody. Antibody localization was detected with an Alexa-conjugated rabbit anti-goat IgG. Original magnification, ϫ630. C, comparison of GRP78/BiP protein levels in cells treated with various ER stress-inducing agents. Total protein lysates (30 g/ml) from wild-type (T24/83), vector-transfected (T24/83-pcDNA), GRP78/ BiP-overexpressing cells (T24/83-GRP78c1) or wild-type cells cultured in the presence of either homocysteine (5 mM), dithiothreitol (2.5 mM), or tunicamycin (10 g/ml) for 18 h were separated by SDS-polyacrylamide gel electrophoresis under reducing conditions. Gels were either stained with Coomassie Blue (upper panel) or immunostained with an anti-KDEL monoclonal antibody, which recognizes GRP78/BiP and GRP94 (lower panel). The migration positions of GRP78/BiP and GRP94 are shown by arrowheads.
FIG. 2. Overexpression of GRP78/BiP suppresses free thrombin generation and prothrombin consumption on the surface of T24/83 cells.
A, free thrombin generation. Normal pooled human plasma was used to measure free thrombin generated on the surface of wild-type (OE), vector-transfected (f), or the GRP78/BiP-overexpressing cell lines, c1 (E) and c2 (छ). Data represent mean Ϯ S.E. of triplicate measurements from four separate experiments. *, p Ͻ 0.001 versus wild-type or vector-transfected cells. B, prothrombin consumption. Normal pooled human plasma was used to measure prothrombin consumption on the surface of wild-type (OE), vector-transfected (f), or the GRP78/BiP-overexpressing cells, c1 and c2 (q). Data represent mean Ϯ S.E. of triplicate measurements from four separate experiments. *, p Ͻ 0.001 versus wild-type or vector-transfected cells.
pared with wild-type and vector-transfected cells (p Ͻ 0.005).
To determine whether GRP78/BiP overexpression directly impaired the conversion of factor VII to VIIa at the cell surface by TF, factor VIIa generation was measured over 30 min using the chromogenic substrate S-2288. As shown in Fig. 3B , the rate of factor VIIa generation on the surface of GRP78/BiPoverexpressing cells was significantly decreased, compared with wild-type and vector-transfected cells (p Ͻ 0.005). The observation that the amidolysis of S-2288 was negligible in the absence of factor VII by 30 min indicates that amidolysis of the substrate correlates with the generation of factor VIIa and is not due to the presence of other cellular factors known to hydrolyze the substrate (i.e. tissue plasminogen activator, kallikrein).
To ensure that the PCA measured was mediated by TF, control experiments measuring the amount of factor Xa generated were performed on wild-type T24/83 cells. Negligible factor Xa was generated on the cell surface upon exclusion of factor VIIa from the reaction, indicating that the generation of factor Xa (which corresponds to PCA) was factor VIIa-TF dependent (Fig. 4A) . Furthermore, the addition of increasing concentrations of a neutralizing anti-human TF antibody prior to measuring PCA decreased the amount of factor Xa generated in a dose-dependent manner, with complete inhibition occurring at 10 g/ml (Fig. 4B) . No inhibition was observed using rabbit IgG (data not shown). These findings are consistent with previously published data that PCA on the surface of T24/83 cells is TF-dependent (69, 70) and provides strong evidence that the generation of factor Xa was mediated exclusively by TF.
Localization of TF on the Cell Surface of T24/83 Cells-To determine whether alterations in TF PCA were the result of changes in the cellular levels of TF, both non-permeabilized (cell surface) and permeabilized (total) T24/83 cells were examined by indirect immunofluorescence using an anti-human TF monoclonal antibody (Fig. 5) . Non-permeabilized cells were characterized by clusters of TF in defined patches distributed over the cell surface (Fig. 5, A-C) . The intensity of TF staining was not decreased in the GRP78/BiP-overexpressing cells (Fig.  5C ), compared with wild-type (Fig. 5A ) or vector-transfected (Fig. 5B) cells. Permeabilized cells exhibited both cell surface and perinuclear staining of TF, a finding consistent with previous studies (72) . Again, the intensity of staining was not decreased in the GRP78/BiP-overexpressing cells (Fig. 5F ), compared with wild-type (Fig. 5D ) or vector-transfected (Fig.  5E ) cells. Nonspecific immunostaining was not detected in cells in which the primary antibody had been omitted or in which preimmune mouse IgG was substituted for the primary antibody (data not shown). Consistent with these findings, immunoprecipitation experiments did not show a decrease in cell surface TF on GRP78/BiP-overexpressing cells, compared with wild-type or vector-transfected cells (Fig. 6A) .
Effects of GRP78/BiP Overexpression on Cell Surface Protein
Levels-To determine whether GRP78/BiP overexpression mediates the levels of other cell surface proteins, intact wild-type, vector-transfected, or GRP78/BiP-overexpressing cells were labeled using NHS-SS-Biotin, a membrane impermeable form of biotin. Following biotinylation, cells were washed in 1ϫ PBS, and total cell lysates were separated on 10% SDS-polyacrylamide gels, transferred to nitrocellulose membranes, and biotinylated proteins detected using HRP-conjugated ExtrAvidin. As shown in Fig. 6B , there was no significant difference in the migration pattern or intensity of staining of cell surface biotinylated proteins among the different cell types (lanes 4 -8) . No staining was observed in the lysates from cells that were not pretreated with NHS-SS-Biotin (lanes 1-4) . Consistent with these findings, the levels of insulin receptor, caveolin-1, and Fas were not altered among the different cell lines (data not shown).
Overexpression of GRP78/BiP Attenuates Ionomycin-or Hydrogen Peroxide-induced TF PCA-Previous studies have demonstrated that increases in cytosolic Ca
2ϩ levels by treatment with the Ca 2ϩ ionophores, ionomycin or A23187, increases TF PCA, at a rate independent of de novo protein synthesis (47) (48) (49) (50) . Treatment of cells with hydrogen peroxide also increases TF PCA, which is independent of an increase in TF protein levels (42, 46) . Given that GRP78/BiP is a Ca 2ϩ -binding protein and protects cells from oxidative stress (5-7), the effects of ionomycin and hydrogen peroxide on cell surface TF PCA were examined. Factor Xa generation was significantly increased in all cell lines exposed to ionomycin or hydrogen peroxide, compared with untreated cells (Fig. 7) . However, the absolute in- Factor Xa generation on the surface of wild-type (T24/83), vector-transfected (T24/83-pcDNA) or GRP78/BiP (T24/83-GRP78) cells was performed by a one-step assay, which directly measures the conversion of factor X to factor Xa, using the chromogenic substrate S-2765. B, rate of VIIa generation. Factor VIIa generation on cell surfaces was performed by a one-step assay that directly measures the conversion of factor VII to factor VIIa, using the chromogenic substrate S-2288. Data represent mean Ϯ S.E. of triplicate measurements from three separate experiments. *, p Ͻ 0.05 versus wild-type or vector-transfected cells. crease in TF PCA upon ionomycin (Fig. 7A) or hydrogen peroxide (Fig. 7B ) treatment was significantly lower (p Ͻ 0.05) in the GRP78/BiP-overexpressing cells, compared with wild-type and vector-transfected control cells. These findings provide evidence that GRP78/BiP overexpression inhibits the stimulation of TF PCA by agents that are known to increase intracellular Ca 2ϩ or oxidative stress. Adenovirus-mediated GRP78/BiP Overexpression Inhibits TF PCA Induced by Viral Infection-To confirm the effect of stable overexpression of GRP78/BiP on TF PCA, an additional approach using adenovirus to overexpress GRP78/BiP was performed. A recombinant adenovirus containing the complete human GRP78/BiP open reading frame under the control of the constitutively expressed CMV promoter (AdV-GRP78) was constructed. As shown in Fig. 8A , GRP78/BiP protein levels were increased ϳ3-fold in T24/83 cells and HASMC following infection with AdV-GRP78, compared with infection with the control virus expressing ␤-galactosidase (AdV-␤-Gal) or uninfected (no virus) cells. In addition, adenovirus-mediated overexpression of GRP78/BiP was not associated with a discernable change in cell surface TF protein levels, compared with uninfected cells or cells infected with AdV-␤-Gal (Fig. 8B ). Adenovirus infection did not significantly affect cell proliferation or cell death (data not shown).
Given that adenovirus infection has been shown to increase TF PCA (33), the effect of GRP78/BiP overexpression on adenovirus-mediated TF PCA was examined. Wild-type T24/83 cells or HASMC were infected with AdV-GRP78 or AdV-␤-Gal and TF PCA was determined. T24/83 cells (Fig. 9A) and HASMC (Fig. 9B) infected with AdV-␤-Gal exhibited an increase in TF PCA, compared with uninfected cells, a finding consistent with previous studies showing that adenoviral infection increases TF PCA (33) . In contrast, TF PCA was not increased in cells infected with AdV-GRP78. Therefore, in addition to attenuating TF PCA stimulated by ionomycin or hydrogen peroxide, GRP78/BiP overexpression also decreases adenovirus-mediated TF PCA.
Adenovirus-mediated GRP78/BiP Overexpression Inhibits TF PCA Induced by Ionomycin or Hydrogen Peroxide-To confirm the observations from the stable cell lines, the effect of adenovirus-mediated GRP78/BiP overexpression on the induction of TF PCA by ionomycin or hydrogen peroxide was examined. Wild-type T24/83 cells and HASMC were infected with AdV-␤-Gal or AdV-GRP78 followed by treatment with ionomycin or hydrogen peroxide and measurement of TF PCA. In both T24/83 cells and HASMC, AdV-GRP78 inhibited the stimulation of TF PCA by ionomycin (Fig. 10A ) or hydrogen peroxide (Fig. 10B) . These findings confirm the results from the stable cell lines and provide further evidence that intracellular Ca 2ϩ and/or oxidative stress play a role in the regulation of TF PCA by GRP78/BiP. Furthermore, the similar effects of GRP78/BiP overexpression on TF PCA in these different cell lines provides evidence for a general cellular mechanism. DISCUSSION TF-dependent thrombin generation plays a critical role in hemostasis after tissue injury and also in the pathogenesis of multiple thrombotic disorders associated with a wide range of diseases, including cardiovascular disease, sepsis and cancer (21) (22) (23) (24) 73) . Despite its importance in coagulation and human disease, the cellular factors that regulate TF expression and/or activity are relatively unknown. In this report, we provide novel evidence that overexpression of GRP78/BiP in the prothrombotic cell line T24/83 prevents cell surface thrombin generation by inhibiting TF PCA. The observation that GRP78/BiP overexpression does not decrease cell surface TF suggests that the inhibition of TF PCA is not due to an impairment in the trafficking of TF through the ER. However, the ability of GRP78/BiP overexpression to attenuate TF PCA induced by ionomycin, hydrogen peroxide or viral infection supports a mechanism involving cellular Ca 2ϩ and/or oxidative stress. These findings demonstrate that alterations in the expression of GRP78/BiP can have profound effects on the prothrombotic characteristics of cells.
Stable overexpression of GRP78/BiP does not cause a decrease in cell surface levels of TF in T24/83 cells. In fact, TF levels are somewhat increased in GRP78/BiP-overexpressing cells, compared with wild-type or vector-transfected cells. This finding is consistent with previous studies demonstrating that GRP78/BiP overexpression increases macrophage colony-stimulating factor (MCSF) expression and secretion in CHO cells (7, 20) . Since overexpression of GRP78/BiP can inhibit the secretion of factor VIII and vWf (7, 20) , structural differences among proteins which affect their association with GRP78/BiP are likely to occur. Indeed, both factor VIII and vWf, but not MCSF, have been shown to stably associate with GRP78/BiP in the ER lumen (7, 20) . Several lines of evidence suggest that GRP78/ BiP does not stably associate with TF or directly alter its activity. First, immunoprecipitation experiments have failed to identify stable complexes between TF and GRP78/BiP in T24/83 cells. 2 Second, the BiP Score program (13) , which has been successfully used to predict BiP binding sites within antibodies and HIV gp160 (13) (14) (15) , indicates a low probability of TF-GRP78/BiP association. Third, TF PCA in rabbit brain thromboplastin is not inhibited by recombinant GRP78/BiP. 2 Taken together, these findings demonstrate that GRP78/BiP chaperone function is not required for the folding/processing of all proteins that transit the ER. However, given that GRP78/ BiP has been shown to bind a number of proteins, GRP78/BiP could potentially regulate TF PCA through its interactions with other proteins/factors, the identities of which are as yet unknown.
The observation that GRP78/BiP overexpression decreases TF PCA without a corresponding decrease in cell surface TF levels may be partly explained given that TF expression does not necessarily correlate with activity. Tissue factor expression and activity are considered to be independently regulated by a two-step activation pathway in which certain cellular factors (such as lipoproteins) regulate synthesis of latent TF while other factors (such as ROS) mediate post-translational modifications of existing cell surface TF to an active form (42, 46) . Based on our findings, it is unlikely that a mechanism involving decreased TF synthesis or impaired trafficking of TF through the ER is responsible for a decrease in TF PCA. This would imply that GRP78/BiP overexpression indirectly alters TF PCA through a mechanism independent of its chaperone activity. In support of this concept, GRP78/BiP overexpression attenuates TF PCA induced by ionomycin, suggesting that alterations in ER Ca 2ϩ stores play an important role in the regulation of TF PCA by GRP78/BiP. Given that GRP78/BiP is a major Ca 2ϩ -binding protein (10, 11) and that TF PCA is mediated by changes in intracellular levels of free Ca 2ϩ (47-50), overexpression of GRP78/BiP could potentially inhibit TF PCA indirectly by sequestering intracellular Ca 2ϩ . Although it is not completely understood as to how alterations in intracellular Ca 2ϩ increase TF PCA, it may involve the production of ROS. It is well established that efflux of Ca 2ϩ from the ER enhances the peroxidase activity of cyclooxygenases and lipoxygenases, thereby leading to the production of ROS (74) . Furthermore, elevated levels of intracellular Ca 2ϩ lead to mitochondrial Ca 2ϩ uptake, mitochondrial dysfunction and the generation of ROS (5, 6, 74) . Oxidative stress has been shown to increase TF PCA (42, 46) , suggesting that changes in intracellular Ca 2ϩ could indirectly alter TF PCA through the generation of ROS. This mechanism is also supported by findings that in contrast to ionomycin, thapsigargin, an inhibitor of the ER Ca 2ϩ -ATPase, does not significantly increase TF PCA and induces a lower intracellular Ca 2ϩ response than ionomycin. 3 The observation that GRP78/BiP overexpression attenuates TF PCA induced by both ionomycin and hydrogen peroxide also suggests a link between intracellular Ca 2ϩ and oxidative stress. In addition, GRP78/BiP overexpression could potentially limit the accessibility of anionic phospholipids essential for TF PCA. Exposure of anionic phospholipids on the outer plasma membrane increases TF PCA (47, 66, 75, 76) and is regulated by Ca 2ϩ levels (47, 75, 77) . Therefore, modulation of any component/cofactors involved in this pathway by GRP78/ BiP could ultimately attenuate TF PCA.
Infection of cultured human vascular endothelial cells with adenovirus, as well as other respiratory viruses, increases TF PCA and expression (33) . Consistent with these findings, we demonstrated that infection of T24/83 cells and HASMC with a recombinant adenovirus expressing ␤-galactosidase increases TF PCA in a dose-dependent manner. However, TF PCA did not increase in T24/83 cells or HASMC infected with a recombinant adenovirus expressing GRP78/BiP. Given that viral infection could potentially increase intracellular Ca 2ϩ concentration (74) , which could lead to the production of ROS, the inhibitory effect of GRP78/BiP on TF PCA induced by viral infection further supports a mechanism involving Ca 2ϩ and/or oxidative stress. This mechanism is also suggested by the observation that adenovirus-mediated delivery of GRP78/BiP inhibits a rise in intracellular Ca 2ϩ caused by hydrogen peroxide, thereby protecting neuronal cells from hydrogen peroxide-mediated cell death (78) .
On the basis of our findings, is there a plausible biological link between GRP78/BiP overexpression and TF PCA? Numer- ous agents and/or conditions, including viral infection, Ca 2ϩ ionophores and homocysteine, that activate TF expression and activity can also induce ER stress (9) . The ability of ER stress to increase TF expression and activity could involve the activation of NFB. It has been reported that ER stress activates NFB through a mechanism involving release of Ca 2ϩ from the ER and the subsequent generation of ROS (74) . This is consistent with previous studies demonstrating that TF PCA is increased by elevations in intracellular Ca 2ϩ and oxidative stress (42, 46 -50) . However, the induction of GRP78/BiP, as well as other ER-resident molecular chaperones, is considered to be a protective mechanism elicited by cells to alleviate the adverse effects of ER stress (58, 59) . Based on our findings, GRP78/BiP overexpression may thus impair TF PCA in an attempt to reduce the thrombotic potential often associated with ER stress agents/conditions. In summary, we have provided novel evidence that overexpression of GRP78/BiP can inhibit TF-mediated thrombin generation at the cell surface. Because TF is a primary determinant of the thrombogenicity of human atherosclerotic plaques, the ability to inhibit TF PCA by modulating GRP78/BiP protein levels could potentially alleviate many TF-dependent pathological conditions, including myocardial infarction and acute arterial injury.
